Laura Kummer

913 total citations
17 papers, 370 citations indexed

About

Laura Kummer is a scholar working on Infectious Diseases, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Laura Kummer has authored 17 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Pathology and Forensic Medicine and 5 papers in Surgery. Recurrent topics in Laura Kummer's work include SARS-CoV-2 and COVID-19 Research (7 papers), Multiple Sclerosis Research Studies (5 papers) and Peripheral Neuropathies and Disorders (3 papers). Laura Kummer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Multiple Sclerosis Research Studies (5 papers) and Peripheral Neuropathies and Disorders (3 papers). Laura Kummer collaborates with scholars based in Germany, Netherlands and United States. Laura Kummer's co-authors include Richard O. Hynes, Novalia Pishesha, Noor Momin, Hidde L. Ploegh, Noor Jailkhani, Steffen Rickelt, Jessica R. Ingram, Michael Dougan, Yushu Joy Xie and Tao Fang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of Neurology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Laura Kummer

15 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Kummer Germany 7 198 130 105 88 63 17 370
Margherita Passariello Italy 14 305 1.5× 165 1.3× 219 2.1× 45 0.5× 137 2.2× 32 589
Gaoxiang Wang China 13 148 0.7× 68 0.5× 162 1.5× 45 0.5× 21 0.3× 64 442
Mark Daris United States 10 279 1.4× 125 1.0× 243 2.3× 47 0.5× 34 0.5× 18 444
Zhinan Xia China 9 155 0.8× 257 2.0× 177 1.7× 82 0.9× 26 0.4× 22 526
Ester Blanco Spain 12 398 2.0× 302 2.3× 115 1.1× 29 0.3× 26 0.4× 31 611
Stefan S. Kachala United States 11 300 1.5× 114 0.9× 129 1.2× 37 0.4× 65 1.0× 20 713
Anna B. Morris United States 10 138 0.7× 175 1.3× 76 0.7× 27 0.3× 38 0.6× 19 337
Nobuhiko Imahashi Japan 14 306 1.5× 283 2.2× 111 1.1× 83 0.9× 21 0.3× 41 622
Joseph Maakaron United States 12 251 1.3× 139 1.1× 79 0.8× 33 0.4× 11 0.2× 65 465
Yuichi Hasegawa Japan 11 155 0.8× 97 0.7× 97 0.9× 57 0.6× 12 0.2× 35 463

Countries citing papers authored by Laura Kummer

Since Specialization
Citations

This map shows the geographic impact of Laura Kummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Kummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Kummer more than expected).

Fields of papers citing papers by Laura Kummer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Kummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Kummer. The network helps show where Laura Kummer may publish in the future.

Co-authorship network of co-authors of Laura Kummer

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Kummer. A scholar is included among the top collaborators of Laura Kummer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Kummer. Laura Kummer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Schmoch, Thomas, Verena Peters, Mária Bartošová, et al.. (2025). Anserine reduces mortality in experimental sepsis by preventing methylglyoxal-induced capillary leakage. EBioMedicine. 114. 105644–105644. 1 indexed citations
2.
Heer, Pleuni Ooijevaar‐de, Maurice Steenhuis, Luuk Wieske, et al.. (2024). Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection. Frontiers in Immunology. 15. 1314507–1314507.
3.
Kempen, Zoé L. E. van, Eileen W Stalman, Laura Kummer, et al.. (2023). Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod. Multiple Sclerosis Journal. 30(3). 443–447. 1 indexed citations
4.
Otto, Markus, et al.. (2022). Können Mesh-Vernebler die prähospitale Aerosoltherapie verbessern? Eine In-vitro-Studie an simulierten Notfallpatient*innen mit Atemnot. Die Anaesthesiologie. 71(10). 758–766. 1 indexed citations
5.
Kempen, Zoé L. E. van, Eileen W Stalman, Maurice Steenhuis, et al.. (2022). SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 94(4). 280–283. 10 indexed citations
6.
Dam, Koos P J van, Eileen W Stalman, Laura Kummer, et al.. (2022). Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination. Frontiers in Neurology. 13. 1032830–1032830. 2 indexed citations
7.
Kempen, Zoé L. E. van, Laura Kummer, Luuk Wieske, et al.. (2022). Severe breakthrough COVID-19 after SARS-CoV-2 booster vaccination in an MS patient on ocrelizumab. PubMed Central. 2. 100072–100072. 1 indexed citations
8.
Kempen, Zoé L. E. van, Maurice Steenhuis, Eileen W Stalman, et al.. (2022). Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis. Annals of Neurology. 93(1). 103–108. 7 indexed citations
9.
Kummer, Laura, et al.. (2021). Modulation of Peripheral CD4+CD25+Foxp3+ Regulatory T Cells Ameliorates Surgical Stress-Induced Atherosclerotic Plaque Progression in ApoE-Deficient Mice. Frontiers in Cardiovascular Medicine. 8. 682458–682458. 3 indexed citations
10.
Boekel, Laura, Laura Kummer, Koos P J van Dam, et al.. (2021). Adverse events after first COVID-19 vaccination in patients with autoimmune diseases. The Lancet Rheumatology. 3(8). e542–e545. 42 indexed citations
11.
Klotz, Rosa, Laura Kummer, Samuel Kilian, et al.. (2021). Intraoperative Fractions of Inspiratory Oxygen Are Associated With Recurrence-Free Survival After Elective Cancer Surgery. Frontiers in Medicine. 8. 761786–761786.
12.
Remes, Anca, Thomas Puehler, Susanne Hille, et al.. (2021). Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue. Molecular Therapy — Methods & Clinical Development. 21. 83–93. 22 indexed citations
13.
Seifert, Robert, Alexander Hermann, Laura Kummer, et al.. (2021). Vesseg. Arteriosclerosis Thrombosis and Vascular Biology. 41(10). 2516–2522. 1 indexed citations
14.
Janssen, Henrike, Laura Kummer, Hans-Jörg Gillmann, et al.. (2020). Sequential Surgical Procedures in Vascular Surgery Patients Are Associated With Perioperative Adverse Cardiac Events. Frontiers in Cardiovascular Medicine. 7. 13–13. 4 indexed citations
15.
Kummer, Laura, Vijith Vijayan, Rawa Arif, et al.. (2020). Vascular Signaling in Allogenic Solid Organ Transplantation – The Role of Endothelial Cells. Frontiers in Physiology. 11. 443–443. 27 indexed citations
16.
Xie, Yushu Joy, Michael Dougan, Noor Jailkhani, et al.. (2019). Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice. Proceedings of the National Academy of Sciences. 116(16). 7624–7631. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026